Revamping Health Management for Sustainable Development Goals: Insights from Kenya, Malawi, and Uganda

By HEOR Staff Writer

July 17, 2023

The potential of Primary Health Care (PHC) in achieving the Sustainable Development Goals (SDGs) is widely acknowledged. In Eastern and Southern Africa, governments have been progressively decentralising health decision-making, making health management a critical aspect of PHC performance. A study published by Oxford, conducted an in-depth political economy analysis in Kenya, Malawi, and Uganda, focusing on local decision-making environments and their impact on health management and governance practices. 

The study involved a comprehensive set of questions for key informants regarding health planning, budgeting, and implementation. These included understanding local processes and their deviations from established guidelines, identification of local health priorities, the impact of health system arrangements such as decentralisation and governance on health plans, and the dynamics of power relationships among the involved actors. The study also explored the processes for community engagement and gathered suggestions for improving the planning process.

 

Findings highlight several complex issues that need attention to strengthen health management and governance. These range from unfinished reforms under decentralisation, underfunded health plans, to counterproductive working environments for managers. 

Their recommendations aim to address these issues by focusing on managerial capacity, community engagement, coordination, and innovative financing. These small improvements can make the overall system more functional and effective. 

However, these challenges are complex and systemic, requiring leadership and engagement from government actors at multiple levels. The ongoing COVID-19 pandemic has further emphasised the need for resilient health systems and a crisis response mechanism.

Reference url

Recent Posts

Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex Dynamics

By João L. Carapinha

October 27, 2025

Pharmaceutical innovation funding in the UK faces scrutiny amid industry claims that low NHS spending deters investments, but this narrative overlooks key drivers like scientific talent, tax incentives, and operational efficiencies rather than drug prices alone. A recent Lancet article critiques ...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fair Resource Allocation

By João L. Carapinha

October 24, 2025

Health technology assessment plays a pivotal role in resource-constrained healthcare systems. How can organizations like NICE, ICER, and Canada's Drug Agency better incorporate novel value elements into economic evaluations? They can do so by adopting a principled framework that evolves beyond tr...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Centered Approvals

By João L. Carapinha

October 23, 2025

The FDA cancer trial guidelines from August 2025 emphasize overall survival (OS) as the key endpoint for oncology drug approvals. If you're wondering how these FDA cancer trial guidelines impact patient outcomes in treatment trials, they shift focus from surrogate measures like progression-free s...